Safety and effectiveness of direct acting antivirals for treatment of hepatitis C virus in patients with solid organ transplantation

Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients

(2018) Khurram Bari et al.   HEPATOLOGY

Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study

(2018) Jagpreet Chhatwal et al.   HEPATOLOGY

Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients

(2018) Patrick B. Trotter et al.   TRANSPLANTATION

Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study

(2017) Varun Saxena et al.   HEPATOLOGY

Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents

(2016) D. Sawinski et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Treatment With Ledipasvir–Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection

(2016) Massimo Colombo et al.   ANNALS OF INTERNAL MEDICINE

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence

(2016) Fred Poordad et al.   HEPATOLOGY

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

(2016) Michael Manns et al.   LANCET INFECTIOUS DISEASES

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation

(2016) S. Ciesek et al.   Transplant Infectious Disease

Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation

(2015) N. Kamar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

(2015) Michael Charlton et al.   GASTROENTEROLOGY

Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant

(2015) Surakit Pungpapong et al.   HEPATOLOGY

Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network

(2015) Robert S. Brown et al.   LIVER TRANSPLANTATION

New Antivirals for Hepatitis C Infection Among Infected Kidney Transplant Recipients: A Case Report

(2015) A. Suarez-Benjumea et al.   TRANSPLANTATION PROCEEDINGS

Successful Treatment of Chronic Hepatitis C Infection With Direct-Acting Antivirals in a Heart Transplant Recipient: A Case Report

(2015) S. Trakroo et al.   TRANSPLANTATION PROCEEDINGS

An Interferon-free Antiviral Regimen for HCV after Liver Transplantation

(2014) Paul Y. Kwo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity

(2011) Ingi Lee et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION